Results 121 to 130 of about 10,488 (195)

5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen. [PDF]

World Allergy Organ J, 2022
van Nunen SA, Burk MB, Burton PK, Ford G, Harvey RJ, Lozynsky A, Pickford E, Rimmer JS, Smart J, Sutherland MF, Thien F, Weber HC, Zehnwirth H, Newbigin E, Katelaris CH.   +14 more
europepmc   +1 more source

Rhinite allergique saisonnière [Seasonal allergic rhinitis]

, 2018
Allergic diseases are currently amongst the most frequent diseases of our time. Of all the allergies in the Western countries, allergic rhinoconjunctivitis is the most common. Its diagnosis is based mainly on the history and the correlation between symptoms and contact with the allergen.
Salvadé, I., Moi, L., Ribi, C., Spertini, F.   +3 more
openaire   +1 more source

Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. <i>J. Clin. Med.</i> 2025, <i>14</i>, 2609. [PDF]

J Clin Med
Gerstlauer M, Hiller J, Raab J, Birkholz K, Tapparo M, Neuhof C, Day L, Rybachuk A, Acikel C, Sahin H, Hebbeler K, Becker S, Vogelberg C, Allekotte S, Kramer MF, The Tapas Study Group.   +15 more
europepmc   +1 more source

COVID-19 lockdown and seasonal allergic rhinitis: our experience in 40 patients. [PDF]

Acta Biomed, 2021
Gelardi M, Trecca E, Fortunato F, Iannuzzi L, Ronca G, Quaranta N, Cassano M.   +6 more
europepmc   +1 more source

Evaluating the Efficacy of Omalizumab in Severe Cedar Seasonal Allergic Rhinitis in Japan. [PDF]

Cureus
Goto T, Miwa T, Hashimoto K, Amesara K, Unno Y, Sakamoto H.   +5 more
europepmc   +1 more source

Synergic Efficacy of a Multicomponent Nutraceutical Add-On Therapy in Seasonal Allergic Rhinitis in Children: A Prospective, Randomized, Parallel-Group Study. [PDF]

J Clin Med
Gori A, Brindisi G, Anania C, Spalice A, Zicari AM.   +4 more
europepmc   +1 more source

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study. [PDF]

Allergy
Layhadi JA, Starchenka S, De Kam PJ, Palmer E, Wu LYD, Keane ST, Fulton WT, Hikmawati P, Meng X, Filipaviciute P, Cutrina Pons A, Oluwayi K, Lis K, Armfield O, Skinner MA, Heath MD, Hewings SJ, Kramer MF, Shamji MH.   +18 more
europepmc   +1 more source

Effect of heat-killed <i>Lacticaseibacillus paracasei</i> KW3110 on mild to moderate seasonal allergic rhinitis symptoms in Japanese adults: a randomized, double-blind, placebo-controlled parallel-group study. [PDF]

Front Nutr
Sugihara Y, Zheng J, Fukushima Y, Nozawa H, Ushida Y, Tsuji R, Okamoto Y, Fujiwara D.   +7 more
europepmc   +1 more source

Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): Rationale and design of a multicentre, randomized, double-blind, placebo-controlled study. [PDF]

Asia Pac Allergy
Wang M, Zhang Y, Li J, Wang C, Zhang L.
europepmc   +1 more source

LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial. [PDF]

Clin Transl Allergy
Guan K, Liu S, Feng Y, Li L, Zhu X, Bill NC, Ma H, Yang J, Han C, Liu H, Wei Q, Shi H, Wang X.   +12 more
europepmc   +1 more source